LSTA has been in the news 326% more than usual
Oct 27, 2025, 8:32 PM
-24.45%
What does LSTA do
Lisata Therapeutics, based in Basking Ridge, New Jersey, focuses on developing therapies for advanced solid tumors, with its lead candidate LSTA1 enhancing anti-cancer drug penetration in tumors. The company also explores CD34+ cell therapy for various diseases, including critical limb ischemia and diabetic kidney disease.
LSTA has been in the news recently: Novartis AG will acquire Avidity Biosciences for $12 billion, paying $72 per share, with the deal expected to close in the first half of 2026. Following the announcement, Avidity's stock experienced an increase, marking it as one of the largest biotech deals of the year.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.